Omnimmune Holdings, Inc. Stock Other OTC
Equities
OMMH
US68216A1043
Biotechnology & Medical Research
Financials (USD)
Sales 2008 | - | Sales 2009 | - | Capitalization | 1.43M |
---|---|---|---|---|---|
Net income 2008 | -5M | Net income 2009 | -1M | EV / Sales 2008 | - |
Net Debt 2008 | 2.3M | Net Debt 2009 | 2.58M | EV / Sales 2009 | - |
P/E ratio 2008 |
-0.55
x | P/E ratio 2009 |
-0.8
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 42.13% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 71 | - |
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+46.62% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |